Although AMPK activity has been repeatedly reported to be related to prostate cancer cell growth and poor prognosis (Park et al., 2009), paradoxically, AMPK activation also induces apoptosis of DU-145 prostate cancer cells (Sauer et al., 2012). Here, PRKAA1 is linked to prostate carcinoma.